FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• ZYBIC (Meloxicam)

Snippet

SUPPL AP for ZYBIC (MELOXICAM)